Onur Sahin

Mr. Onur Sahin

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Toshiaki IwaseToshiaki Iwase
Toshiaki Iwase
TSTushaar Vishal Shrimanker
Tushaar Vishal Shrimanker
RRRuben Rodriguez-Bautista
Ruben Rodriguez-Bautista
OSOnur Sahin
Onur Sahin
AJAnjali James
Anjali James
Naoto T UenoNaoto T Ueno
Naoto T Ueno
The purpose of this study was to determine the change in overall survival (OS) for patients with de novo metastatic breast cancer (dnMBC) over time. We conducted a retrospective cohort study with 1981 patients with dnMBC diagnosed between January 1995 and December 2017 at The University of Texas MD Anderson Cancer Center. OS was measured from the date of diagnosis of dnMBC. OS was compared between patients diagnosed during different time periods: 5-year periods and periods defined according to when key agents were approved for clinical use. The median OS was 3.4 years. The 5- and 10-year OS rates improved over time across both types of time periods. A subgroup analysis showed that OS improved significantly over time for the estrogen-receptor-positive/HER2-positive (ER+/HER2+) subtype and exhibited a tendency toward improvement over time for the ER-negative (ER−)/HER2+ subtype. In addition, median OS was significantly longer in patients with non-inflammatory breast cancer (p = 0.02) and patients with ER+ disease, progesterone-receptor-positive disease, HER2+ disease, lower nuclear grade, locoregional therapy, and metastasis to a single organ (all p < 0.0001). These findings showed that OS at 5 and 10 years after diagnosis in patients with dnMBC improved over time. The significant improvements in OS over time for the ER+/HER2+ subtype and the tendency toward improvement for the ER−/HER2+ subtype suggest the contribution of HER2-targeted therapy to survival.

4 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Toshiaki IwaseToshiaki Iwase
Toshiaki Iwase
APAaroh Parikh
Aaroh Parikh
SDSeyedeh S. Dibaj
Seyedeh S. Dibaj
YSYu Shen
Yu Shen
TSTushaar Vishal Shrimanker
Tushaar Vishal Shrimanker
Naoto T UenoNaoto T Ueno
Naoto T Ueno
Our previous study indicated that a high amount of visceral adipose tissue was associated with poor survival outcomes in patients with early breast cancer who received neoadjuvant chemotherapy. However, inconsistency was observed in the prognostic role of body composition in breast cancer treatment outcomes. In the present study, we aimed to validate our previous research by performing a comprehensive body composition analysis in patients with a standardized clinical background. We included 198 patients with stage III breast cancer who underwent neoadjuvant chemotherapy between January 2007 and June 2015. The impact of body composition on pathologic complete response and survival outcomes was determined. Body composition measurements had no significant effect on pathologic complete response. Survival analysis showed a low ratio of total visceral adipose tissue to subcutaneous adipose tissue (V/S ratio ≤ 34) was associated with shorter overall survival. A changepoint method determined that a V/S ratio cutoff of 34 maximized the difference in overall survival. Our study indicated the prognostic effect of body composition measurements in patients with locally advanced breast cancer compared to those with early breast cancer. Further investigation will be needed to clarify the biological mechanism underlying the association of V/S ratio with prognosis in locally advanced breast cancer.

1 November 2022 in Biomaterials
Verified
Journal Article
Closed access
SRSubhiksha Raghuram
Subhiksha Raghuram
YMYuri Mackeyev
Yuri Mackeyev
JSJessica Symons
Jessica Symons
YZYasmin Zahra
Yasmin Zahra
VGValeria Gonzalez
Valeria Gonzalez
SKSunil Krishnan
Sunil Krishnan

30 March 2025 in Cancer
Verified
Journal Article
Closed access
OSOnur Sahin
Onur Sahin
SKSerageldin Kamel
Serageldin Kamel
KWKareem A. Wahid
Kareem A. Wahid
CDCem Dede
Cem Dede
NTNicolette Taku
Nicolette Taku
MGMultidisciplinary Oropharyngeal Cancer Extra‐Nodal Extension (OPC ENE) Assessment Working Group
Multidisciplinary Oropharyngeal Cancer Extra‐Nodal Extension (OPC ENE) Assessment Working Group

28 March 2025 in Science Advances
Verified
Journal Article
Open access
OSOnur Sahin
Onur Sahin
YMYuri Mackeyev
Yuri Mackeyev
GVGeraldine V. Vijay
Geraldine V. Vijay
SRSoumyabrata Roy
Soumyabrata Roy
Ashok Kumar MeiyazhaganAshok Kumar Meiyazhagan
Ashok Kumar Meiyazhagan
SKSunil Krishnan
Sunil Krishnan
Inadequate light penetration in tissues restricts photodynamic therapy to treating only superficial tumors. To enable x-ray–excited photodynamic therapy (XPDT) that targets deep-seated tumors, we synthesized a nanoscintillator-photosensitizer complex containing 5% Eu-doped Y 2 O 3 fluorescing at 611 nanometers and decorated with SiO 2 containing the scintillation-coupled photosensitizer methylene blue and a polyethylene glycol coating [PEGylated Y 2 O 3 :Eu@SiO 2 -methylene blue (pYSM)]. When irradiated, pYSMs generate singlet oxygen species in vitro, causing cytotoxicity with hallmarks of immunogenic cell death (calreticulin translocation to the cell membrane). Intravenously administered pYSMs home passively to pancreatic tumor xenografts and, upon 10 gray irradiation, cause significant tumor regression ( P < 0.01). On combining XPDT with anti-PD1 immunotherapy, a distant nonirradiated tumor also regresses via an increase in intratumoral activated CD8 + cytotoxic T cells. Collectively, we advance a systemically delivered XPDT strategy that mediates an antitumor effect in both irradiated and nonirradiated (abscopal) tumors when coupled with immunotherapy, converting an immunologically “cold” tumor to an immunologically “hot” tumor.

26 February 2023 in medRxiv
Verified
Preprint
Open access
PDF file
OSOnur Sahin
Onur Sahin
KWKareem A. Wahid
Kareem A. Wahid
NTNicolette Taku
Nicolette Taku
RHRenjie He
Renjie He
MNMohamed A. Naser
Mohamed A. Naser
CFClifton David Fuller
Clifton David Fuller
Importance: Extranodal extension (pENE) is a critical prognostic factor in oropharyngeal cancer (OPC) that drives therapeutic disposition. Determination of pENE from radiological imaging has been associated with high inter-observer variability. However, the impact of clinician specialty on human observer performance of imaging-detected extranodal extension (iENE) remains poorly understood. Objective: To characterize the impact of clinician specialty on the accuracy of pre-operative iENE in human papillomavirus-positive (HPV+) OPC using computed tomography (CT) images. Design, Setting, and Participants: This prospective observational human performance study analyzed pre-therapy CT images from 24 HPV+ OPC patients, with duplication of 6 scans (n=30) of which 21 were pathologically confirmed pENE. Thirty-four expert observers, including 11 radiologists, 12 surgeons, and 11 radiation oncologists, independently assessed these scans for iENE and reported human-detected radiologic criteria and observer confidence. Main Outcomes and Measures: The primary outcomes included accuracy, sensitivity, specificity, area under the receiver operating characteristic curve (AUC), and Brier score for each physician, compared to ground-truth pENE. The significance of radiographic signs for prediction of pENE were determined through logistic regression analysis. Fleiss’ kappa measured interobserver agreement, and Hanley-MacNeil AUC discrimination testing. Results: Median accuracy across all specialties was 0.57 (95%CI 0.39 to 0.73), with no specialty showing discriminate performance greater than random estimation (median AUC 0.64, 95%CI 0.44 to 0.83). Significant differences between radiologists and surgeons in Brier scores (0.33 vs. 0.26, p < 0.01), radiation oncologists and surgeons in sensitivity (0.48 vs. 0.69, p > 0.1), and radiation oncologists and radiologists/surgeons in specificity (0.89 vs. 0.56, p > 0.1). Indistinct capsular contour and nodal necrosis were significant predictors of correct pENE status among all specialties. Interobserver agreement was weak for all the radiographic criteria, regardless of specialty ( κ <0.6). Conclusions and Relevance: Multiobserver testing shows physician discrimination of HPV+OPC pENE on pre-operative CT remains non-different than blind guessing, with high inter-rater variability and low diagnostic accuracy, regardless of clinician specialty. While minor differences in diagnostic performance among specialties are noted, they do not significantly affect the overall poor agreement and discrimination rates observed. The findings underscore the need for further research into automated detection systems or enhanced imaging techniques to improve the accuracy and reliability of iENE assessments in clinical practice. Abstract Figure: Visual